Immunodiagnostic Systems Holdings PLC is a specialist in vitro diagnostic solution provider to the clinical laboratory market. The Company develops, manufactures and markets immunoassays and automated immunoanalyser technologies. It operates through three business segments: Automated IVD, Manual IVD, and Licensing & Technology. The automated IVD business consists of 25-OH Vitamin D, specialties and instrument sales. The automated IVD business also consists of the sale or placement of its IDS-iSYS instrument, in addition to selling automated assays and consumables for use in these instruments. The Manual IVD business sells manual assays, radio immunoassays (RIA) and ELISA kits (EIA) to labs. Its assay development is focused in the clinical areas, such as calcium metabolism, bone metabolism, chronic kidney disease, hypertension, fertility and growth. Its subsidiaries include Immunodiagnostic Systems Limited, Immunodiagnostic Systems Nordic A/S and Immunodiagnostic Systems France SAS.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:IDH
- CUSIP: N/A
- Web: N/A
- Market Cap: £86.77 million
- Outstanding Shares: 29,415,000
- 50 Day Moving Avg: GBX 301.57
- 200 Day Moving Avg: GBX 255.21
- 52 Week Range: GBX 110 - GBX 318
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £38.41 million
- Price / Sales: 2.26
- Book Value: GBX 1.88 per share
- Price / Book: 1.57
- Average Volume: 4,647 shs.
Frequently Asked Questions for Immunodiagnostic Systems Holdings PLC (LON:IDH)
What is Immunodiagnostic Systems Holdings PLC's stock symbol?
Immunodiagnostic Systems Holdings PLC trades on the London Stock Exchange (LON) under the ticker symbol "IDH."
How often does Immunodiagnostic Systems Holdings PLC pay dividends? What is the dividend yield for Immunodiagnostic Systems Holdings PLC?
Immunodiagnostic Systems Holdings PLC declared a dividend on Wednesday, June 22nd. Investors of record on Thursday, July 21st will be given a dividend of GBX 1.20 per share on Friday, August 19th. This represents a yield of 0.94%. The ex-dividend date of this dividend is Thursday, July 21st. The official announcement can be viewed at this link. View Immunodiagnostic Systems Holdings PLC's Dividend History.
Who are some of Immunodiagnostic Systems Holdings PLC's key competitors?
Some companies that are related to Immunodiagnostic Systems Holdings PLC include Charles Stanley Group plc (CAY), Rhythmone PLC (RTHM), Acal plc (ACL), Epwin Group PLC (EPWN), James Latham plc (LTHM), Ideagen PLC (IDEA), Morses Club PLC (MCL), CityFibre Infrastructure Holdings PLC (CITY), 32Red Plc (TTR), Sinclair Pharma PLC (SPH), Mysale Group PLC (MYSL), Focusrite PLC (TUNE), Allergy Therapeutics plc (AGY), IFG Group PLC (IFP), Oxford BioMedica plc (OXB), Charles Taylor PLC (CTR), STV Group Plc. (STVG) and Atalaya Mining PLC (ATYM).
How do I buy Immunodiagnostic Systems Holdings PLC stock?
Shares of Immunodiagnostic Systems Holdings PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Immunodiagnostic Systems Holdings PLC stock cost?
One share of Immunodiagnostic Systems Holdings PLC stock can currently be purchased for approximately GBX 295.
Consensus Ratings for Immunodiagnostic Systems Holdings PLC (LON:IDH) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Immunodiagnostic Systems Holdings PLC (LON:IDH)
(Data available from 5/28/2015 forward)
|6/23/2015||N+1 Singer||Reiterated Rating||Sell||GBX 294|
Earnings History for Immunodiagnostic Systems Holdings PLC (LON:IDH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Immunodiagnostic Systems Holdings PLC (LON:IDH)
Current Year EPS Consensus Estimate: $5.48 EPS
Dividend History by Quarter for Immunodiagnostic Systems Holdings PLC (LON:IDH)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Immunodiagnostic Systems Holdings PLC (LON:IDH)Insider Trades by Quarter for Immunodiagnostic Systems Holdings PLC (LON:IDH)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/22/2017||Paul James Martin||Insider||Buy||3,000||GBX 277||£8,310|
|1/20/2017||Till Bengt Campe||Insider||Buy||1,800||GBX 249||£4,482|
|1/11/2017||Till Bengt Campe||Insider||Buy||1,500||GBX 245||£3,675|
|7/8/2016||Kaspar,Klaus Peter||Insider||Buy||4,100||GBX 142||£5,822|
|7/1/2016||Kaspar,Klaus Peter||Insider||Buy||5,000||GBX 138||£6,900|
|6/30/2016||Kaspar,Klaus Peter||Insider||Buy||6,000||GBX 137||£8,220|
|6/23/2016||Martin,Paul James||Insider||Buy||10,000||GBX 132||£13,200|
Headline Trends for Immunodiagnostic Systems Holdings PLC (LON:IDH)
Latest Headlines for Immunodiagnostic Systems Holdings PLC (LON:IDH)
Immunodiagnostic Systems Holdings PLC (IDH) Chart for Sunday, May, 28, 2017